SS-31 (Elamipretide) Dosage Guide

Complete guide to SS-31 (Elamipretide) dosing protocols, administration methods, and safety considerations for research purposes.

Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.

Recommended Dosage

Clinical trials have used IV infusions of 0.25mg/kg for acute conditions. Subcutaneous dosing protocols for research use typically range from 1-5mg daily.

Administration Method

Can be administered IV or subcutaneously. Most clinical research has used IV administration for cardiac conditions.

Side Effects to Monitor

Generally well-tolerated. Clinical trials reported injection site reactions and occasional headache.

Safety Considerations & Risks

Failed to meet primary endpoints in some heart failure trials. Long-term effects still being studied. Expensive for research use.